DELPHARMA: what changed
DELPHARMA
Largest movements
- Stocks and contracts -€29,391
down €29,391 (-17.9%), from €164,622 to €135,231
- Cash +€27,179
up €27,179 (+243%), from €11,169 to €38,349
mainly Net result for the year (+€43,239) and Stocks and contracts (+€29,391)
- Receivables within one year +€21,741
up €21,741 (+30.3%), from €71,678 to €93,418
of which Trade receivables: +€13,729
- Tangible fixed assets +€5,915
up €5,915 (+24.8%), from €23,821 to €29,736
of which Other tangible fixed assets: +€8,763
- Trade debts +€28,068
up €28,068 (+27.3%), from €103,003 to €131,071
- Reserves +€25,239
up €25,239 (+53.2%), from €47,455 to €72,694
- Current portion of long-term debt -€23,990
down €23,990 (-85.2%), from €28,167 to €4,177
- Other debts +€5,812
up €5,812 (+17.7%), from €32,917 to €38,729
- Short-term financial debts -€4,851
down €4,851 (-99.7%), from €4,867 to €16
- Staff costs +€6,302
up €6,302 (+63.7%), from €9,888 to €16,190
- Taxes -€5,719
down €5,719 (-28.8%), from €19,850 to €14,130
- Financial charges +€5,218
up €5,218 (+97.2%), from €5,368 to €10,586
- Gross operating margin +€2,589
up €2,589 (+2.9%), from €88,021 to €90,611
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €276,933 | €302,800 | +€25,868 | +9.3% |
| Fixed assets | 21/28 | €24,046 | €29,961 | +€5,915 | +24.6% |
| Tangible fixed assets | 22/27 | €23,821 | €29,736 | +€5,915 | +24.8% |
| Plant, machinery and equipment | 23 | €108 | €0 | -€108 | -100.0% |
| Furniture and vehicles | 24 | €5,571 | €2,831 | -€2,739 | -49.2% |
| Other tangible fixed assets | 26 | €18,142 | €26,905 | +€8,763 | +48.3% |
| Financial fixed assets | 28 | €225 | €225 | = | 0.0% |
| Current assets | 29/58 | €252,887 | €272,839 | +€19,952 | +7.9% |
| Stocks and contracts in progress | 3 | €164,622 | €135,231 | -€29,391 | -17.9% |
| Stocks | 30/36 | €164,622 | €135,231 | -€29,391 | -17.9% |
| Amounts receivable within one year | 40/41 | €71,678 | €93,418 | +€21,741 | +30.3% |
| Trade receivables | 40 | €69,885 | €83,614 | +€13,729 | +19.6% |
| Other amounts receivable | 41 | €1,793 | €9,805 | +€8,012 | +447% |
| Cash at bank and in hand | 54/58 | €11,169 | €38,349 | +€27,179 | +243% |
| Deferred charges and accrued income | 490/1 | €5,418 | €5,841 | +€423 | +7.8% |
| Total equity and liabilities | 10/49 | €276,933 | €302,800 | +€25,868 | +9.3% |
| Equity | 10/15 | €86,047 | €111,286 | +€25,239 | +29.3% |
| Contributions | 10/11 | €20,000 | €20,000 | = | 0.0% |
| Reserves | 13 | €47,455 | €72,694 | +€25,239 | +53.2% |
| Distributable reserves | 133 | €47,455 | €72,694 | +€25,239 | +53.2% |
| Profit (loss) carried forward | 14 | €18,592 | €18,592 | = | 0.0% |
| Amounts payable | 17/49 | €190,886 | €191,514 | +€629 | +0.3% |
| Amounts payable within one year | 42/48 | €190,886 | €191,514 | +€629 | +0.3% |
| Current portion of amounts payable after more than one year | 42 | €28,167 | €4,177 | -€23,990 | -85.2% |
| Financial debts | 43 | €4,867 | €16 | -€4,851 | -99.7% |
| Credit institutions | 430/8 | €4,867 | €16 | -€4,851 | -99.7% |
| Trade debts | 44 | €103,003 | €131,071 | +€28,068 | +27.3% |
| Suppliers | 440/4 | €103,003 | €131,071 | +€28,068 | +27.3% |
| Taxes, remuneration and social security | 45 | €21,932 | €17,522 | -€4,410 | -20.1% |
| Taxes | 450/3 | €21,689 | €17,283 | -€4,406 | -20.3% |
| Remuneration and social security | 454/9 | €243 | €239 | -€4 | -1.7% |
| Other amounts payable | 47/48 | €32,917 | €38,729 | +€5,812 | +17.7% |
| Non-recurring operating income | 76A | - | €16,093 | +€16,093 | |
| Remuneration, social security and pensions | 62 | €9,888 | €16,190 | +€6,302 | +63.7% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €5,435 | €5,535 | +€99 | +1.8% |
| Other operating charges | 640/8 | €1,042 | €952 | -€90 | -8.7% |
| Gross operating margin | 9900 | €88,021 | €90,611 | +€2,589 | +2.9% |
| Operating profit (loss) | 9901 | €71,656 | €67,935 | -€3,722 | -5.2% |
| Financial income | 75/76B | €33 | €20 | -€12 | -37.6% |
| Recurring financial income | 75 | €33 | €20 | -€12 | -37.6% |
| Financial charges | 65/66B | €5,368 | €10,586 | +€5,218 | +97.2% |
| Recurring financial charges | 65 | €5,368 | €10,586 | +€5,218 | +97.2% |
| Profit (loss) for the period before taxes | 9903 | €66,321 | €57,369 | -€8,951 | -13.5% |
| Income taxes | 67/77 | €19,850 | €14,130 | -€5,719 | -28.8% |
| Profit (loss) for the period | 9904 | €46,471 | €43,239 | -€3,232 | -7.0% |
| Profit (loss) for the period to be appropriated | 9905 | €46,471 | €43,239 | -€3,232 | -7.0% |
Next steps
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 7 November 2026 via checked.be.